Write your message
Volume 6, Issue 4 (Fall 2021)                   J Obstet Gynecol Cancer Res 2021, 6(4): 224-227 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sharma H K. Malignant Pericardial Effusion Secondary to Ovarian Adenocarcinoma Presenting with Cardiac Tamponade: A Case Report. J Obstet Gynecol Cancer Res. 2021; 6 (4) :224-227
URL: http://jogcr.com/article-1-296-en.html
Department of Pathology, Hospital Bagdogra, Dist Darjeeling, West Bengal, India , hemant1303@gmail.com
Abstract:   (470 Views)

Malignant pericardial effusion presenting with cardiac tamponade is a rare manifestation of metastatic gynecological cancer. Our patient, a 62-year-old female was presented with papillary serous adenocarcinoma of the right ovary in 2016. She was treated with interval cytoreduction surgery and platinum-based chemotherapy until 2018. Now, she presented with sudden onset dyspnea, tachypnea, tachycardia with hypotension, and distended jugular venous pressure. Echocardiography confirmed a large pericardial effusion with mild bilateral pleural effusion. She underwent an emergent pericardiocentesis which yielded 350 mL of hemorrhagic fluid and cytological examination of smears confirmed the presence of metastatic adenocarcinoma cells. The patient was managed conservatively and discharged after one week of hospitalization with a referral to the oncology center for further treatment. With increasing longevity and improved chemotherapeutic regimens, cases of malignant pericardial effusion with cardiac tamponade are on the rise, and therefore, clinicians need to be familiar with the prompt diagnosis and management of this life-threatening disease process.

Full-Text [PDF 422 kb]   (205 Downloads) |   |   Full-Text (HTML)  (56 Views)  
Systematic Review: Case Report | Subject: Gynecology Oncology
Received: 2020/11/15 | Accepted: 2021/02/12 | Published: 2021/08/11

1. Thomakos N, Diakosavvas M, Machairiotis N, Fasoulakis Z, Zarogoulidis P, Rodolakis A. Rare distant metastatic disease of ovarian and peritoneal carcinomatosis: A review of the literature. Cancers. 2019 Aug;11(8):1044. [DOI:10.3390/cancers11081044] [PMID] [PMCID]
2. Thurber DL, Edwards JE, Achor RW. Secondary malignant tumors of the pericardium. Circulation. 1962;26:228-241 [DOI:10.1161/01.CIR.26.2.228] [PMID]
3. Nagarsheth NP, Harrison M, Kalir T, Rahaman J. Malignant pericardial effusion with cardiac tamponade in a patient with metastatic vaginal adenocarcinoma. Int J Gynecol Cancer. 2006; 16(3):1458-61. [DOI:10.1111/j.1525-1438.2006.00584.x] [PMID]
4. Lestuzzi C. Neoplastic pericardial disease: Old and current strategies for diagnosis and management. World J Cardiol. 2010; 2(9):270-9. [DOI:10.4330/wjc.v2.i9.270] [PMID] [PMCID]
5. Blich M., Malkin L., Kapeliovich M. Malignant pericardial tamponade secondary to papillary serous adenocarcinoma of the ovary. Isr Med Assoc J. 2007; 9(4):337-8
6. Feferkorn I, Shai A, Gemer O, Auslender R, Lavie O. The natural history of pericardial tamponade secondary to recurrent ovarian carcinoma - A case report and review of the literature. Gynecol Oncol Rep. 2014; 10:53-5. [DOI:10.1016/j.gynor.2014.06.001] [PMID] [PMCID]
7. Fatema, N., Rahman, W., Samdani, T., Rahman, M. A., Rahman, A., Siddiqua, A., Aziz, A., Sultan, M. A., Sharmin, F., & Arzu, J. Incidence of Malignancy Related Pericardial Effusion in a Tertiary Hospital. Uni Heart J.2017; 12(1), 23-5. [DOI:10.3329/uhj.v12i1.34020]
8. Petrofsky M. Management of Malignant Pericardial Effusion. J Adv Pract Oncol. 2014; 5(4):281-289. [DOI:10.6004/jadpro.2014.5.4.5]
9. Smith FE, Lane M, Hudgins PT: Conservative management of malignant pericardial effusion. Cancer .1974; 33:47-57 https://doi.org/10.1002/1097-0142(197401)33:1<47::AID-CNCR2820330110>3.0.CO;2-8 [DOI:10.1002/1097-0142(197401)33:13.0.CO;2-8]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.